Stocklytics Platform
Asset logo for symbol GLSI
Greenwich LifeSciences
GLSI37
$9.74arrow_drop_down0.61%-$0.06
Asset logo for symbol GLSI
GLSI37

$9.74

arrow_drop_down0.61%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Greenwich LifeSciences (GLSI) Stocklytics Forecast

The stock price of Greenwich LifeSciences, Inc. (GLSI) has been the subject of much speculation and prediction in recent months. Analysts and investors are eager to determine the future trajectory of the company's stock and make informed investment decisions. While it is difficult to accurately predict the exact stock price of GLSI, various factors can be considered to form a forecast for the future. One such factor is the overall performance of the company in the biotechnology sector. GLSI specializes in the development of immunotherapy treatments for breast cancer, and if their research and clinical trials are successful, it could lead to significant growth in the stock price.
Another important consideration for predicting GLSI's stock price is the market sentiment and investor sentiment towards the company. Positive news, such as successful trial results or regulatory approvals, can drive up the stock price, while negative news or setbacks can have the opposite effect. Monitoring these factors and staying updated on the latest developments in the company and the biotechnology industry can help investors make more accurate predictions regarding GLSI's stock price forecast. However, it is important to note that investing in biotechnology stocks can be highly volatile and speculative. It is always recommended to conduct thorough research and consult with financial professionals before making any investment decisions.
add Greenwich LifeSciences to watchlist

Keep an eye on Greenwich LifeSciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Greenwich LifeSciences (GLSI) stock?

Analysts have set a target price of $58 for Greenwich LifeSciences (GLSI), based on forecasts from 2 analysts. The predicted price range extends from a high of $78 to a low of $38. This represents a potential increase of up to 700.74% and a decrease of 290.1% from the current price of $9.74. These forecasts are as of 2021 Jan 26.
help

What are the analyst ratings for Greenwich LifeSciences (GLSI) stock?

Currently, there are no analyst ratings available for Greenwich LifeSciences (GLSI), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Greenwich LifeSciences (GLSI) stock?

At present, there is no AI or machine-learning-based price prediction available for Greenwich LifeSciences (GLSI) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level